Tocilizumab for Painful Chronic Pancreatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Pancreatitis, Chronic
Interventions
DRUG

Tocilizumab 20 MG/ML [Actemra]

Tocilizumab 8 mg/kg every four weeks for 24 weeks.

DRUG

Sodium Chloride 0.9% Inj

Placebo (Sodium chloride) every four weeks for 24 weeks.

Trial Locations (1)

9000

RECRUITING

Centre for Pancreatic Diseases and Mech-Sense research laboratory, Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

University of Aarhus

OTHER

collaborator

Viborg Regional Hospital

OTHER

collaborator

Stanford University

OTHER

collaborator

Haukeland University Hospital

OTHER

lead

Soren Schou Olesen

OTHER